While our primary outcome analysis focused on baseline CKD-MBD biomarkers, including PTH, calcium, and phosphorus, to determine optimal cut-off levels and their associations with IHD, we acknowledge the need for further investigation into the relationship between time-dependent PTH levels and IHD risk. The gene discussed is PTH; the disease is Marchiafava-Bignami disease.